The promise of retinoids to fight against cancer
The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Retinoids have a reputation for being both detrimental and beneficial: they are teratogens, but they also have tumour-suppressive capacity. Cell biology and genetics have significantly improved our understanding of the mechanisms that underlie the anti-proliferative action of retinoids. Recent elucidation of the pathways that are activated by retinoids will help us to exploit the beneficial aspects of this powerful class of compounds for cancer therapy and prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apart from the well-known indications in hypovitaminosis and skin diseases, retinoids have been successfully used in treating cancer”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
In the citing paper
“The FDA has approved ATRA to treat cystic acne and several cancers, such as some lymphoma and leukemia”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
Citations
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · cited 8×
“a | The t(15;17) chromosomal translocation generates the PML–RARα fusion protein that, in contrast to RARα, can efficiently dimerize or oligomerize, thereby recruiting multiple HDAC complexes and leading to ‘super-repression’ of target genes.”
BackgroundInfluentialKamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411601 · Cited by 1,898
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics
McPherson, K. (2000) · BMJ · doi:10.1136/bmj.321.7261.624 · Cited by 1,570
Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231205 · Cited by 1,365
The retinoids—Biology, chemistry and medicine
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80793-5 · Cited by 1,178
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development
Niederreither, K., Subbarayan, V., Dollé, P., & Chambon, P. (1999) · Nature Genetics · doi:10.1038/7788 · Cited by 1,077
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
BackgroundGrignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
Background
Research works printed but not linked: 1
- Moon, R. C., Mehta, R. G. & Rao, K. J. V. N. in The Retinoids (eds Sporn, M. B., Roberts, A. B. & Goodman, D. S.) 573–595 (Raven, New York, 1994).
Cited by
Items 201–300 of 784
Retinoic-acid-induced apoptosis in leukemia cells
Jimenez-Lara, A. M., Clarke, N., Altucci, L., & Gronemeyer, H. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.08.006 · Cited by 59
Self-citationLiu, S., Huang, H., Lü, X., Goliński, M., Comesse, S., Watt, D. S., Grossman, R. B., & Moscow, J. A. (2003) · PubMed · Cited by 49
Silicon Analogues of the RXR‐Selective Retinoid Agonist SR11237 (BMS649): Chemistry and Biology
Lippert, W. P., Burschka, C., Götz, K., Kaupp, M., Ivanova, D. I., Gaudon, C., Sato, Y., Antony, P., Rochel, N., Moras, D., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900090 · Cited by 49
Self-citationObora, A., Shiratori, Y., Okuno, M., Adachi, S., Takano, Y., Matsushima‐Nishiwaki, R., Yasuda, I., Yamada, Y., Akita, K., Sano, T., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.36369 · Cited by 49
Klopper, J. P., Hays, W. R., Sharma, V., Baumbusch, M. A., Hershman, J. M., & Haugen, B. R. (2004) · PubMed · Cited by 49
Oral and systemic photoprotection
Chen, A. C., Damian, D. L., & Halliday, G. M. (2014) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12100 · Cited by 45
A 3D bioprinted hydrogel mesh loaded with all-trans retinoic acid for treatment of glioblastoma
Mirani, B., Pagan, E., Shojaei, S., Duchscherer, J., Toyota, B. D., Ghavami, S., & Akbari, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.007 · Cited by 50
Therapeutic effects of histone deacetylase inhibitors on kidney disease
Chun, P. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0998-7 · Cited by 52
Hao, X., Bose, M., Lambert, J. D., Ju, J., Lü, G., Lee, M., Park, S., Husain, A., Wang, S., Sun, Y., et al. (2007) · Nutrition and Cancer · doi:10.1080/01635580701365050 · Cited by 48
“RXRα is a nuclear receptor that acts as a transcription factor on the binding of the ligand and retinoids and plays a significant role in regulating cell growth and differentiation as well as suppressing tumorigenesis (29,30).”
BackgroundSingh, A. T. K., Evens, A. M., Anderson, R. J., Beckstead, J. A., Natesan, S., Sassano, A., Bhalla, S., Yang, S., Platanias, L. C., Forte, T. M., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08209.x · Cited by 48
“Several investigations have provided evidence that retinoids, such as all trans retinoic acid (ATRA), are useful agents in cancer therapy as they exhibit a central role in cell growth, differentiation, and apoptosis (Altucci & Gronemeyer, 2001; Soprano et al, 2004).”
BackgroundKumar, V., Rahman, M., Gahtori, P., Al-Abbasi, F. A., Anwar, F., & Kim, H. S. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1860939 · Cited by 49
Retinoic acid regulates cell cycle genes and accelerates normal mouse liver regeneration
Liu, H., Ly, I., Hu, Y. C., & Wan, Y. Y. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.003 · Cited by 46
“Despite the essential role of endogenous RA on liver regeneration, there lacks a consensus on the effects of exogenous RA on hepatocyte proliferation in vivo, since previous studies have yielded conflicting results [5–8].”
ResultKanamori, T., Shimizu, M., Okuno, M., Matsushima‐Nishiwaki, R., Tsurumi, H., Kojima, S., & Moriwaki, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2006.00384.x · Cited by 46
Vargas, F. A., Gätjens-Boniche, O., Vargas-Méndez, E., Valverde, B., & Díaz, C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.06.047 · Cited by 46
“Retinoids have been extensively used for the treatment of promyelocytic leukemia [17–19].”
BackgroundMethodPML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia
Ohnishi, K. (2007) · International Journal of Clinical Oncology · doi:10.1007/s10147-007-0694-6 · Cited by 50
The retinoid anticancer signal: mechanisms of target gene regulation
Liu, T., Bohlken, A., Kuljaca, S., Lee, M., Nguyen, T. G., Smith, S. A., Cheung, B. B., Norris, M. D., Haber, M., Holloway, A. J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602700 · Cited by 49
“In addition to the classical nuclear RA signalling mechanism, covalent binding of RA or RAR to other cellular macromolecules may exert other retinoid effects (Altucci and Gronemeyer, 2001; Balmer and Blomhoff, 2002).”
BackgroundDevelopment of cancer chemopreventive drugs based on mechanistic approaches
Steele, V. E., & Kelloff, G. J. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.04.018 · Cited by 46
Retinoic Acid Receptor-β2 Promoter Methylation in Random Periareolar Fine Needle Aspiration
Bean, G. R., Scott, V. M., Yee, L., Ratliff, B. E., Troch, M. M., Seo, P. H., Bowie, M. L., Marcom, P. K., Slade, J., Kimler, B. F., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0580 · Cited by 46
“(Cancer Epidemiol Biomarkers Prev 2005;14(4):790–8)”
BackgroundInfluentialCarvacrol as a Prospective Regulator of Cancer Targets/Signalling Pathways
Singh, J., Luqman, S., & Meena, A. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220705142954 · Cited by 232
The Potential of Cryptophyte Algae in Biomedical and Pharmaceutical Applications
Abidizadegan, M., Peltomaa, E., & Blomster, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618836 · Cited by 52
“…of compounds including vitamin A and the main apocarotenoid produced in algae) have been mainly represented in preventing the growth and development of various sorts of tumors, including skin, breast, oral, lung, prostatic and bladder cancers (Altucci and Gronemeyer, 2001; Jonas et al., 2015).”
BackgroundOvcharenko, D., Stölzel, F., Poitz, D. M., Fierro, F. A., Schaich, M. A., Neubauer, A., Kelnar, K., Davison, T. S., Müller‐Tidow, C., Thiede, C., et al. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.07.008 · Cited by 50
Current Mechanistic Approaches to the Chemoprevention of Cancer
Steele, V. E. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.078 · Cited by 45
“The progression of clonal evolution in epithelial cancers is well documented and described (Boone et al., 1992; Altucci and Gronemeyer, 2001).”
BackgroundThe effect of regulating molecules on the structure of the PPAR-RXR complex
Amber-Vitos, O., Chaturvedi, N., Nachliel, E., Gutman, M., & Tsfadia, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.003 · Cited by 48
Mourikis, T. P., Benedetti, L. G., Foxall, E., Temelkovski, D., Nulsen, J., Perner, J., Cereda, M., Lagergren, J., Howell, M. T., Yau, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10898-3 · Cited by 45
Patel, J. B., Mehta, J., Belosay, A., Sabnis, G. J., Khandelwal, A., Brodie, A. M., Soprano, D. R., & Njar, V. C. O. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603705 · Cited by 47
“The ability of ATRA as well as other natural and synthetic retinoids to modulate a variety of important functions such as cell growth and differentiation, induction of apoptosis and prevention of angiogenesis is well documented (Dragnev et al, 2000; Altucci and Gronemeyer, 2001; Boyle, 2001; Fontana and Rishi, 2002).”
BackgroundNaringenin targets ERK 2 and suppresses UVB ‐induced photoaging
Jung, S. K., Ha, S. J., Jung, C. H., Kim, Y. T., Lee, H., Kim, M. O., Lee, M., Mottamal, M., Bode, A. M., Lee, K. W., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12780 · Cited by 46
“Although ATRA is an effective and well-known anti-photoaging agent, several studies have indicated that it might have unfavourable side effects [14, 15].”
BackgroundInduction of senescence‐associated growth inhibitors in the tumor‐suppressive function of retinoids
Roninson, I. B., & Dokmanovic, M. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10320 · Cited by 44
“Retinoids are also routinely used in several premalignant diseases, including leukoplakia, actinic keratosis, and cervical dysplasia, and in chemoprevention of skin cancer in patients with xeroderma pigmentosum [Altucci and Gronemeyer, 2001].”
BackgroundInfluentialZhang, J., Zuo, Z., Wang, Y., Yu, A., Chen, Y., & Wang, C. (2010) · Chemosphere · doi:10.1016/j.chemosphere.2010.09.057 · Cited by 48
The Role of Retinoid Deficiency and Estrogens as Cofactors in Cervical Cancer
Gariglio, P., Gutiérrez, J., Cortés-Malagón, E. M., & Vázquez, J. (2009) · Archives of Medical Research · doi:10.1016/j.arcmed.2009.08.002 · Cited by 52
Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM
Yin, W., Rossin, A., Clifford, J. L., & Gronemeyer, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209410 · Cited by 43
“The strong cell differentiation potential of retinoids has led to their use in both chemotherapy and chemoprevention of human cancers (Hong and Sporn, 1997; Hansen et al., 2000; Altucci and Gronemeyer, 2001; Sun and Lotan, 2002).”
BackgroundSelf-citationKim, Y., Chongviriyaphan, N., Liu, C., Russell, R. M., & Wang, X.-D. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi340 · Cited by 51
Jeong, H., Kim, Y.-R., Kim, K. N., Choe, J.-G., Chung, J.-K., & Kim, M.-K. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.07.004 · Cited by 43
“Moreover, RA is well-known for its anticancer effects, as it induces the differentiation and apoptosis of tumor cells and inhibits tumor progression [15,16].”
BackgroundDavies, M. R., Ribeiro, L. R., Downey-Jones, M. D., Needham, M., Oakley, C., & Wardale, J. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24550 · Cited by 42
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis
Milella, M., Konopleva, M. Y., Precupanu, C., Tabe, Y., Ricciardi, M. R., Gregorj, C., Collins, S. J., Carter, B. Z., D’Angelo, C., Petrucci, M. T., et al. (2006) · Blood · doi:10.1182/blood-2006-05-024679 · Cited by 42
RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells
Shan, P., Pu, J., Yuan, A., Shen, L., Shen, L., Chai, D., & He, B. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.074 · Cited by 42
Guidoboni, M., Zancai, P., Cariati, R., Rizzo, S., Col, J. D., Pavan, A., Gloghini, A., Spina, M., Cuneo, A., Pomponi, F., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.587.65.2 · Cited by 42
“Moreover, retinoids, alone or in combination with other drugs, were shown to have some activity also in hematologic malignancies different from acute promyelocytic leukemia, including juvenile chronic myeloid leukemia, myelodysplastic syndrome, and cutaneous T-cell lymphoma (25, 26).”
BackgroundMichael, A., Hill, M. E., Maraveyas, A., Dalgleish, A. G., & Lofts, F. J. (2006) · Clinical Oncology · doi:10.1016/j.clon.2006.11.008 · Cited by 42
In vitro and in vivo assessment of vitamin A encapsulation in a liposome–protein delivery system
Rovoli, M., Pappas, I. S., Lalas, S. I., Gortzi, O., & Kontopidis, G. A. (2018) · Journal of Liposome Research · doi:10.1080/08982104.2018.1502314 · Cited by 42
“The pleiotropic actions and their power to drive cells into differentiation and death offer great promise for cancer therapy (Altucci and Gronemeyer 2001), and the beneficial effects of retinoid based differentiation therapy have been impressively shown in the case of acute promyelocytic leukaemia (Ozpolat et al.”
BackgroundWang, X., Ye, T., Xue, B., Yang, M., Li, R., Xu, X., Zeng, X. Y., Tian, N., Bao, L., & Huang, Y. (2020) · Gastric Cancer · doi:10.1007/s10120-020-01111-2 · Cited by 44
Leclerc, D., Lévesque, N., Cao, Y., Deng, L.-Y., Wu, Q. H., Powell, J., Sapienza, C., & Rozen, R. R. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0198 · Cited by 41
Shimizu, M., Suzui, M., Deguchi, A., Lim, J. T. E., & Weinstein, I. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0714-3 · Cited by 44
Bai, Z., Zhang, Z., Ye, Y., & Wang, S. (2010) · Cell Biology International · doi:10.1042/cbi20090481 · Cited by 45
“Redifferentiation is a cell-transformation process and does not produce negative effects in normal cells (Altucci and Gronemeyer, 2001).”
BackgroundStra6, a retinoic acid-responsive gene, participates in p53-induced apoptosis after DNA damage
Carrera, S., Cuadrado‐Castano, S., Samuel, J., Jones, G. D. D., Villar, E., Lee, S. W., & Macip, S. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.14 · Cited by 43
“that retinoids are known teratogens, but they can also inhibit tumour cell growth.(16) One of the main active effectors of the pathway is all-trans RA (ATRA), which can regulate the”
InfluentialZolfaghari, R., Cifelli, C. J., Lieu, S. O., Chen, Q., Li, N., & Ross, A. C. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00494.2006 · Cited by 42
“Due to their differentiation-promoting properties, retinoids have become important drugs in the treatment of a variety of skin disorders, leukemias, and other cancers (4).”
BackgroundYing, M., Zhou, X., Zhong, L., Lin, N., Jing, H., Luo, P., Yang, X., Song, H., Yang, B., & He, Q. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0433 · Cited by 40
Doi, A., Ishikawa, K., Shibata, N., Ito, E., Fujimoto, J., Yamamoto, M., Shiga, H., Mochizuki, H., Kawamura, Y., Goshima, N., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.09.005 · Cited by 44
“Their ligand, retinoic acid (RA), activates these heterodimers, consequently leading to differentiation, apoptosis, and cell cycle arrest through transcriptional activation (Bastien and RochetteEgly, 2004; Altucci and Gronemeyer, 2001).”
BackgroundPinto, N. R., DuBois, S. G., Marachelian, A., Diede, S. J., Taraseviciute, A., Bender, J. G., Tsao-Wei, D. D., Groshen, S. G., Reid, J. M., Haas-Kogan, D. A., et al. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27023 · Cited by 42
Synergistic Effects of PPAR γ Ligands and Retinoids in Cancer Treatment
Shimizu, M., & Moriwaki, H. (2008) · PPAR Research · doi:10.1155/2008/181047 · Cited by 46
“Abnormalities in the expression and function of retinoids and their receptors play an important role in influencing the development of various human malignancies and, therefore, might be critical targets for cancer chemoprevention and/or chemotherapy [24].”
BackgroundTakano, Y., Adachi, S., Okuno, M., Muto, Y., Yoshioka, T., Matsushima‐Nishiwaki, R., Tsurumi, H., Ito, K., Friedman, S. L., Moriwaki, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309148200 · Cited by 40
Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review
Murchison, A. P., Walrath, J. D., & Washington, C. V. (2011) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2010.02422.x · Cited by 42
Shankaranarayanan, P., Rossin, A., Khanwalkar, H., Álvarez, S., Álvarez, R., Jacobson, A., Nebbioso, A., de Lera, Á. R., Altucci, L., & Gronemeyer, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.029 · Cited by 39
“The anticancer activity of retinoids is well established, and the induction of differentiation and/or apoptosis is a hallmark of this therapeutic potential (Altucci and Gronemeyer, 2001; Altucci et al., 2007).”
BackgroundSelf-citationTargeting Truncated Retinoid X Receptor-α by CF31 Induces TNF-α–Dependent Apoptosis
Wang, G., Jiang, F., Duan, Y., Zeng, Z., Chen, F., Dai, Y., Chen, J., Liu, J., Liu, J., Zhou, H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2038 · Cited by 39
“Cancer Res; 73(1) January 1, 2013 Cancer Research 308”
BackgroundInfluentialSuzui, M., Shimizu, M., Masuda, M., Lim, J. T. E., Yoshimi, N., & Weinstein, I. B. (2004) · PubMed · Cited by 39
Bullinger, L., Schlenk, R. F., Götz, M., Botzenhardt, U., Hofmann, S., Russ, A. C., Babiak, A., Zhang, L., Schneider, V., Döhner, K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2524 · Cited by 40
“Clin Cancer Res; 19(9) May 1, 2013 2562”
BackgroundInfluentialRetinoid Differentiation Therapy for Common Types of Acute Myeloid Leukemia
Brown, G., & Hughes, P. (2012) · Leukemia Research and Treatment · doi:10.1155/2012/939021 · Cited by 39
“These patients are very hard to treat with current regimens, and whilst younger patients have benefited from more intensive approaches to treatment, there have not been substantial improvements to outcomes for the elderly [12].”
BackgroundParrella, E., Gianni’, M., Fratelli, M., Barzago, M. M., Raška, I., Diomede, L., Kurosaki, M., Pisano, C., Carminati, P., Merlini, L., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023614 · Cited by 44
“The activity of classic retinoids is the consequence of selective antiproliferative and cytodifferentiating effects that are mediated predominantly by specific nuclear receptors of the RAR and RXR families (Altucci and Gronemeyer, 2001).”
BackgroundChen, Y., Dokmanovic, M., Stein, W. D., Ardecky, R., & Roninson, I. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0581 · Cited by 41
“The antitumor effect of retinoids is most often attributed to the induction of differentiation, but these compounds were also shown to stop the growth of tumor cells by inducing apoptosis or accelerated senescence (1, 2).”
BackgroundAlltrans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett's cells
Hormi-Carver, K. K., Feagins, L. A., Spechler, S. J., & Souza, R. F. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00237.2006 · Cited by 41
RARγ acts as a tumor suppressor in mouse keratinocytes
Chen, C. F., Goyette, P., & Lohnes, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207682 · Cited by 39
“The biological functions of RA are mediated by two members of the nuclear receptor family, the retinoic acid receptors (RARa, RARb and RARg and their isoforms) and the retinoid X receptors (RXRa, RXRb and RXRg and their isoforms) (Chambon 1996; Altucci and Gronemeyer 2001; Wei 2003).”
BackgroundInfluentialGRIM-19 associates with the serine protease HtrA2 for promoting cell death
Ma, X., Kalakonda, S., Srinivasula, S. M., Reddy, S. P., Platanias, L. C., & Kalvakolanu, D. V. (2007) · Oncogene · doi:10.1038/sj.onc.1210287 · Cited by 40
“Despite their efficacy against primary cancers of the skin, head and neck (Altucci and Gronemeyer, 2001), they are clinically ineffective for treating advanced cancers.”
BackgroundE-box-independent regulation of transcription and differentiation by MYC
Uribesalgo, I., Buschbeck, M., Gutiérrez, A., Teichmann, S., Demajo, S., Kuebler, B., Nomdedeu, J. F., Martín‐Caballero, J., Roma, G., Benitah, S. A., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2355 · Cited by 43
ZRF1: a novel epigenetic regulator of stem cell identity and cancer
Aloia, L., Demajo, S., & Croce, L. D. (2015) · Cell Cycle · doi:10.4161/15384101.2014.988022 · Cited by 40
“Interestingly, RARamediated repression also involves the regulation of histone acetylation, and the histone deacetylases (HDACs) are fundamental components of the RARa-associated corepressor complexes.(49) Further investigation is required to understand to which extent ZRF1 is involved in this complex regulatory mecha…”
BackgroundAbalı, R., Yüksel, M. A., Aktaş, C., Celik, C., Güzel, S., Erfan, G., & Şahin, Ö. (2013) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2013.04.010 · Cited by 38
“The physiological functions of retinoids include the control of proliferation, apoptosis and differentiation in normal cells during growth and development; they also have tumour-suppressive capacity (Altucci and Gronemeyer, 2001).”
BackgroundKelsey, L. S., Katoch, P., Johnson, K. E., Batra, S. K., & Mehta, P. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032846 · Cited by 39
Expression and functional analysis of two lycopene β-cyclases from citrus fruits
Zhang, L., Ma, G., Shirai, Y. M., Kato, M., Yamawaki, K., Ikoma, Y., & Matsumoto, H. (2012) · Planta · doi:10.1007/s00425-012-1690-2 · Cited by 41
“Altucci and Gronemeyer (2001) reported that β-cryptoxanthin played an 74 important role in the prevention of some diseases, especially cancers, because of 75 its antioxidant activity.”
BackgroundChen, A. J., Li, J., Jannasch, A., Mutlu, A. S., Wang, M. C., & Cheng, J. (2018) · ChemPhysChem · doi:10.1002/cphc.201800545 · Cited by 39
Ligand Recognition by RAR and RXR Receptors: Binding and Selectivity
Sussman, F., & de Lera, A. R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050285w · Cited by 37
Büttner, M. W., Burschka, C., Daiss, J. O., Ivanova, D. I., Rochel, N., Kammerer, S., Peluso‐Iltis, C., Bindler, A., Gaudon, C., Germain, P., et al. (2007) · ChemBioChem · doi:10.1002/cbic.200700182 · Cited by 47
Self-citationGluyas, J. B. G., Burschka, C., Dorrich, S., Vallet, J., Gronemeyer, H., & Tacke, R. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25989c · Cited by 43
Self-citationCampos, H., Irwig, M. S., Baylín, A., Rifai, N., & El‐Sohemy, A. (2002) · Journal of Nutrition · doi:10.1093/jn/131.10.3161 · Cited by 40
Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds
Montrone, M., Martorelli, D., Rosato, A., & Dolcetti, R. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009788452435 · Cited by 43
“In the absence or RAR ligands, or in the presence of RAR antagonists, RAR-RXR heterodimers form DNA multiprotein complexes with transcriptional co-repressors, such as hystone deacetylases (HDACs), silencing mediator for retinoid and thyroid receptors (SMRT), and nuclear receptor co-repressor (NcoR) [25-27].”
BackgroundLuo, X., & Ross, A. C. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100517 · Cited by 38
KUO, H., KUO, W., Lee, Y. S., Wang, C. C., & Tseng, T. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.04.007 · Cited by 37
Liu, S., Stromberg, A. J., Tai, H., & Moscow, J. A. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.477.2.8 · Cited by 37
“teristic translocation and superrepression of the retinoic acid a receptor, making these cells functionally vitamin A deficient and unable to undergo terminal differentiation (2).”
BackgroundHaffez, H., Chisholm, D. R., Valentine, R., Pohl, E., Redfern, C. P. F., & Whiting, A. (2017) · MedChemComm · doi:10.1039/c6md00680a · Cited by 43
Klopper, J. P., Hays, W. R., Sharma, V., Baumbusch, M. A., Hershman, J. M., & Haugen, B. R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1011.3.8 · Cited by 52
Suzui, M., Shimizu, M., Masuda, M., Lim, J. T. E., Yoshimi, N., & Weinstein, I. B. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.309.3.3 · Cited by 37
“As mentioned above, RARh, when activated by a ligand, can stimulate further expression of RARh (3, 9), ACR can”
BackgroundMethodInfluentialDNA methylation associated with polycomb repression in retinoic acid receptor β silencing
Moison, C., Sénamaud‐Beaufort, C., Fourrière, L., Champion, C., Ceccaldi, A., Lacomme, S., Daunay, A., Tost, J., Arimondo, P. B., & Guieysse‐Peugeot, A. (2013) · The FASEB Journal · doi:10.1096/fj.12-210971 · Cited by 39
“These properties convey RA antitumoral activities, and it has been reported that it can suppress cancer cell growth (8, 9).”
BackgroundChaperone-mediated autophagy substrate proteins in cancer
Tang, Y. C., Wang, X., Liu, Z.-H., Sun, Y.-M., Tang, Y., & Zhou, D.-H. (2017) · Oncotarget · doi:10.18632/oncotarget.17583 · Cited by 41
“By mediating active repression through nuclear receptors, N-CoR involves in cellular biological processes, including tumor initiation, differentiation and progression [80, 81].”
BackgroundFunaki, M., Kitabayashi, J., Shimakami, T., Nagata, N., Sakai, Y., Takegoshi, K., Okada, H., Murai, K., Shirasaki, T., Oyama, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17285-2 · Cited by 37
Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles
Okuda, T., Kawakami, S., Higuchi, Y., Satoh, T., Oka, Y., Yokoyama, M., Yamashita, F., & Hashida, M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.019 · Cited by 37
Qian, D. Z., Ren, M., Wei, Y., Wang, X., van de Geijn, F., Rasmussen, C. S., Nakanishi, O., Sacchi, N., & Пили, Р. (2005) · The Prostate · doi:10.1002/pros.20209 · Cited by 36
“These agents exert their effects mainly via members of the nuclear receptor super-family, the retinoid acid receptors (RARs) and the retinoid X receptors (RXRs) [1].”
BackgroundBrtko, J. (2007) · Biomedical Papers · doi:10.5507/bp.2007.033 · Cited by 36
Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin
Schultze, E., Ourique, A. F., Yurgel, V. C., Begnini, K. R., Thurow, H. S., de Leon, P. M. M., Campos, V. F., Dellagostin, O. A., Guterres, S. S., Pohlmann, A. R., et al. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.003 · Cited by 36
Chou, S., Chan, H.-H., Peng, H.-Y., Liou, M.-J., & Wu, T.-S. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.08.018 · Cited by 35
Bellis, F. D., Carafa, V., Conte, M., Rotili, D., Petraglia, F., Matarese, F., Françoijs, K., Ablain, J., Valente, S., Castellano, R., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2568 · Cited by 38
“7, 8), thereby affecting a variety of biologic processes in essential all cell types, such as cell proliferation, differentiation, and apoptosis (9, 10).”
Self-citationPatched Knockout Mouse Models of Basal Cell Carcinoma
Nitzki, F., Becker, M., Frommhold, A., Schulz‐Schaeffer, W., & Hahn, H. (2012) · Journal of Skin Cancer · doi:10.1155/2012/907543 · Cited by 38
“Retinoids are ligands of the retinoic acid receptor (RAR) and the retinoid X receptor (RXR) and show tumor-suppressive capacity in several tumor entities [71].”
BackgroundTan, M., Li, Y., Yang, R., Xi, N., & Sun, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027726 · Cited by 38
“its activity in inducing differentiation, apoptosis, and growth arrest, RA has been long used for the treatment and prevention of various types of human cancers [19,27,28,29,30], particularly as a differentiation therapy agent for the treatment of AML (Acute Myeloid Leukemia) [31,32].”
BackgroundRetinoic acid receptor α promotes autophagy to alleviate liver ischemia and reperfusion injury
Zhong, C., Pu, L.-Y., Fang, M.-M., Gu, Z., Rao, J.-H., & Wang, X.-H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12381 · Cited by 37
The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis
Karamouzis, M. V., Konstantinopoulos, P. A., & Papavassiliou, A. G. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0311 · Cited by 36
“Retinoids modulate the growth and differentiation of cancer cells by activating gene transcription through their cognate nuclear receptors (68).”
BackgroundKanki, K., Akechi, Y., Ueda, C., Tsuchiya, H., Shimizu, H., Ishijima, N., Toriguchi, K., Hatano, E., Endo, K., Hirooka, Y., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.024 · Cited by 37
“Accumulating data from epidemiological and experimental studies have suggested that retinoids, which are vitamin A derivatives, prevent cancer in various organs including the stomach, breast, lung, prostate, and liver [2–7].”
BackgroundD’Amato, L., Dell’Aversana, C., Conte, M., Ciotta, A., Scisciola, L., Carissimo, A., Nebbioso, A., & Altucci, L. (2015) · Epigenetics · doi:10.4161/15592294.2014.988035 · Cited by 37
“One of the alternative therapies in cancer treatment relies on the use of differentiation inducers, whose application has often been restricted by the presence of specific genetic features in leukemia, as exemplified by the administration of retinoic acid for the treatment of APL.56,57 It is tempting to hypothesize th…”
BackgroundSelf-citationOral and Systemic Photoprotection
González, S., Gilaberte, Y., & Juarranz, Á. (2016) · Springer eBooks · doi:10.1007/978-3-319-29382-0_22 · Cited by 39
Qian, L., Zolfaghari, R., & Ross, A. C. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002840 · Cited by 34
de Conti, A., Kuroiwa‐Trzmielina, J., Horst, M. A., Bassoli, B. K., Chagas, C. E. A., Purgatto, E., Cavalher, F. P., Camargo, A. A., Jordão, A. A., Vannucchi, H., et al. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.04.010 · Cited by 34
“They may also have a place in HCC treatment and prevention [14,15].”
BackgroundProinflammatory Homeobox Gene, ISX , Regulates Tumor Growth and Survival in Hepatocellular Carcinoma
Hsu, S., Wang, L., Lee, K.-T., Chen, Y.-L., Liu, K.-Y., Suen, J., Chai, C., & Wang, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2795 · Cited by 35
“Retinoid-induced signaling is important in regulating cell growth, differentiation, and development (25) and found to abnormally express and highly associated with tumor development in many malignances, including HCCs (26).”
BackgroundStromal retinoic acid receptor β promotes mammary gland tumorigenesis
Liu, X., Nugoli, M., Laferrière, J., Saleh, S. M. I., Rodrigue‐Gervais, I. G., Saleh, M., Park, M., Hallett, M. T., Muller, W. J., & Giguère, V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011845108 · Cited by 38
“Another biologically and clinically important attribute of RA and other natural and synthetic derivatives of vitamin A, collectively referred to as “retinoids,” is their potent inhibitory effect on the growth and survival of cancer cells originating from various tissues, including the breast (8).”
BackgroundTatebe, H., Shimizu, M., Shirakami, Y., Sakai, H., Yasuda, Y., Tsurumi, H., & Moriwaki, H. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.019 · Cited by 33
“The transcriptional activation by p300 and CREB binding protein (CBP), both of which are histone acetyltransferases and thus controlling the transcription of RARE target genes [3], is stimulated by co-expression of p21 [31].”
BackgroundThe pan-cancer pathological regulatory landscape
Falco, M. M., Bleda, M., Carbonell‐Caballero, J., & Dopazo, J. (2016) · Scientific Reports · doi:10.1038/srep39709 · Cited by 40
Chuang, S. T., Cruz, S., & Narayanaswami, V. (2020) · Nanomaterials · doi:10.3390/nano10050906 · Cited by 35
Metadata
- Authors
- Altucci, L., & Gronemeyer, H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature Reviews Cancer
- Published
- 2001-12
- Volume
- 1
- Issue
- 3
- Pages
- 181-193
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1964224609
- Cited by
- 773
- References
- 147
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 16 · 2023: 18 · 2022: 12 · 2021: 16 · 2020: 20 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 25 · 2015: 36 · 2014: 25 · 2013: 32 · 2012: 47
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- retinoids, cancer therapy, cancer prevention, tumor suppression, antiproliferative mechanism, teratogenicity, cell proliferation
- MeSH terms
- Antineoplastic Agents, Cell Differentiation, Forecasting, Humans, Models, Biological, Morphogenesis, Neoplasm Proteins, Neoplasms, Retinoids, Skin Neoplasms, Structure-Activity Relationship, Vitamin A, Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, Transcriptional Activation, Gene Expression Regulation, Neoplastic, Anticarcinogenic Agents, Apoptosis, Receptors, Retinoic Acid, Transcription Factor AP-1, Dimerization, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.